NCT04741334View on ClinicalTrials.gov

Mild Head Injury, Antiplatelets, and Anticoagulants

CompletedOBSERVATIONAL
Enrollment

2,127

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
Craniocerebral TraumaCerebral Hemorrhage
Interventions
DRUG

direct anticoagulant

exposure to direct anticoagulant

DRUG

antiplatelet drugs

exposure to antiplatelet drugs

DRUG

Dicumarols

exposure to dicumarols

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04741334 - Mild Head Injury, Antiplatelets, and Anticoagulants | Biotech Hunter | Biotech Hunter